Filtered By:
Specialty: Medical Devices
Procedure: Angiography
This page shows you your search results in order of date.
Order by Relevance | Date
Total 17 results found since Jan 2013.
The diagnosis of intracranial artery stenosis in patients with stroke by transcranial Doppler ultrasound: A meta-analysis
CONCLUSION: Doppler ultrasound has good consistency with conventional methods for the diagnosis of intracranial artery stenosis in patients with a history of stroke. Different reference standards may affect sensitivity and specificity; when CTA was used as the reference standard, the consistency of the TCD in the diagnosis of intracranial artery stenosis in stroke patients was relatively good.PMID:37661896 | DOI:10.3233/THC-220844
Source: Technology and Health Care - September 4, 2023 Category: Medical Devices Authors: Wen-Juan Liu Source Type: research
RapidAI is Set to Acquire EndoVantage for an Undisclosed Sum
M&A is still a thing during the COVID-19 Pandemic. Advanced stroke imaging firm, RapidAI is acquiring EndoVantage, developer of the Find, Track, and Treat comprehensive cerebral aneurysm management platform.
Menlo Park, CA-based RapidAI said this acquisition can help it expand its scope, from ischemic stroke to hemorrhagic stroke and now aneurysm.
EndoVantage was started at Mayo Clinic and Arizona State University has developed a powerful award-winning computational platform that provides comprehensive cerebral aneurysm management, automating the entire workflow from initial assessment, growth monitoring, to treatment ...
Source: MDDI - June 10, 2020 Category: Medical Devices Tags: Business Cardiovascular Source Type: news
Boston Scientific Recalls Angiographic Catheters Due to Injuries
At least nine people have been injured by a faulty cateter tip on Boston Scientific's Imager II 5F Angiographic Catheters, FDA reported this week. The company initiated a recall of the device in February that includes 6,130 of the catheters distributed between July 16, 2018 and Nov. 26, 2019. Click here for a full list of affected lot numbers.
The catheters are used to provide a pathway to deliver contrast agents to blood vessels. FDA said there is a potential for the catheter tip to become detached during a patient procedure or during procedure preparation. According to the recall notice from FDA, use of the a...
Source: MDDI - April 7, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news
Japan approves iSchemaView ’ s Rapid stroke imaging device
iSchemaView today announced that it received registration approval in Japan for its Rapid imaging platform.
The company received registration approval through the Japanese Pharmaceutical Affairs Law and through a third party review by the Japanese Assn. for the Advancement of Medical Equipment for the Rapid imaging platform.
Rapid is designed to give physicians a fast, fully automated and easy-to-interpret imaging system that can help doctors make clinical decisions about stroke.
“Stroke remains the fourth most common cause of death in Japan, and as the population ages, stroke is likely to become an increasing health...
Source: Mass Device - July 8, 2019 Category: Medical Devices Authors: Danielle Kirsh Tags: Cardiovascular Hospital Care Imaging ischemaview Source Type: news
IschemaView launches Rapid Angio neuroimaging system
Medical imaging dev IschemaView said yesterday that it launched its Rapid Angio neuroimaging system designed for use in the angiography suite.
The Menlo Park, Calif.-based company said that it partnered with Siemens (NYSE:SI) to integrate the Rapid software with Siemens’ SyngoDynaCT multiphase system for the newly launched imaging solution.
Siemens’ SyngoDyna CT Multiphase is a 3D image acquisition technique which uses multiple rotations of a C-arm system to acquire multi-phasic 3D representation of the brain and its perfusion.
“The Rapid Angio module, by combining the best-in-class syngoDynaCT system...
Source: Mass Device - March 1, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging Neurological ischemaview Source Type: news
HeartFlow wins Japanese reimbursement for FFRct analysis
HeartFlow said yesterday that it won reimbursement coverage from the Japanese Ministry of Health, Labor and Welfare for its HeartFlow FFRct fractional flow reserve analysis.
The Redwood City, Calif.-based company said that it has already received approval from the Japanese Pharmaceuticals and Medical Devices Agency, and that reimbursement will go into effect beginning on December 1.
“When a patient presents with symptoms suggesting CAD, we want to be able to quickly and effectively diagnose patients while reducing the need for unnecessary tests or invasive procedures. In clinical studies, we were able to see firstha...
Source: Mass Device - November 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Featured Imaging Software / IT HeartFlow Source Type: news
Neural Analytics touts 95% accuracy for TCD platform in Expedite trial
Neural Analytics today released initial results from the Expedite study of its Transcranial Doppler Tech platform, touting 95% accuracy in the early detection of acute ischemic stroke due to large vessel occlusion.
Data from the study was presented at the 26th annual European Stroke Conference this week in Berlin.
The 45-subject trial examined the use of TCD scans in patients experiencing computer tomography angiography confirmed acute ischemic stroke due to large vessel occlusion of the internal carotid artery or middle cerebral artery.
Scans with the TCD platform were analyzed with 2 different stroke assessment algorith...
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Diagnostics Neurological Ultrasound Neural Analytics Source Type: news
UPDATE: Stryker recalls select re-sterilized AngioDynamics Soft-VU angio caths
Updated to include comment from Stryker and to adjust “reprocessed” language to “re-sterilized”
Stryker‘s (NYSE:SYK) Sustainability Solutions biz said it recalled a select number of re-sterilized AngioDynamics (NSDQ:ANGO) Soft Vu omni flush angiographic catheters due to reports of tip separation.
AngioDynamics said it is not associated with the recall, and that the devices affected have their own FDA clearance and are “specifically Stryker Sustainability Solutions Products.”
The devices were “part of Stryker’s (formerly Ascent Healthcare Solutions) open-but-unused program...
Source: Mass Device - July 26, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Food & Drug Administration (FDA) Recalls Vascular AngioDynamics Inc. Stryker Source Type: news
Stryker recalls select reprocessed AngioDynamics Soft-VU angio caths
Stryker‘s (NYSE:SYK) Sustainability Solutions biz is recalling a select number of reprocessed AngioDynamics (NSDQ:ANGO) Soft Vu omni flush angiographic catheters due to reports of tip separation.
AngioDynamics said it is not associated with the recall, and that the devices affected have their own FDA clearance as reprocessed devices and are “specifically Stryker Sustainability Solutions Products.”
The FDA has labeled the recall as Class I. Class I recall designations, the agency’s most serious classification of recall, are used when there is a reasonable probability that product use could cause serious...
Source: Mass Device - July 26, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Food & Drug Administration (FDA) Recalls Vascular AngioDynamics Inc. Stryker Source Type: news
TCT 2015: Thrombectomy no benefit in Medtronic’s Export studies
Thrombus aspiration in heart attack patients showed no benefit and raised the risk of stroke, according to a pair of studies of percutaneous coronary interventions using Medtronic‘s (NYSE:MDT) Export aspiration catheter, presented today at the annual Transcatheter Cardiovascular Therapies conference in San Francisco.
Early thrombectomy’s promise Totaled?
The 10,064-patient Total study compared PCI alone and PCI with thrombectomy in ST-elevated myocardial infarctions within 12 hours of onset. The primary endpoint (a composite of cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or class...
Source: Mass Device - October 13, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiovascular Clinical Trials Medtronic TCT 2015 Source Type: news
